230 related articles for article (PubMed ID: 26078001)
1. Pharmacodynamic Activity of Dapivirine and Maraviroc Single Entity and Combination Topical Gels for HIV-1 Prevention.
Dezzutti CS; Yandura S; Wang L; Moncla B; Teeple EA; Devlin B; Nuttall J; Brown ER; Rohan LC
Pharm Res; 2015 Nov; 32(11):3768-81. PubMed ID: 26078001
[TBL] [Abstract][Full Text] [Related]
2. Maraviroc and reverse transcriptase inhibitors combinations as potential preexposure prophylaxis candidates.
Herrera C; Armanasco N; García-Pérez J; Ziprin P; Olejniczak N; Alcamí J; Nuttall J; Shattock RJ
AIDS; 2016 Apr; 30(7):1015-25. PubMed ID: 26854808
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic correlations using fresh and cryopreserved tissue following use of vaginal rings containing dapivirine and/or maraviroc in a randomized, placebo controlled trial.
Dezzutti CS; Richardson-Harman N; Rohan LC; Marzinke MA; Hoesley CJ; Panther L; Johnson S; Nuttall JP; Nel A; Chen BA;
Medicine (Baltimore); 2016 Jul; 95(28):e4174. PubMed ID: 27428211
[TBL] [Abstract][Full Text] [Related]
4. Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings: A Double-Blind Randomized Trial.
Chen BA; Panther L; Marzinke MA; Hendrix CW; Hoesley CJ; van der Straten A; Husnik MJ; Soto-Torres L; Nel A; Johnson S; Richardson-Harman N; Rabe LK; Dezzutti CS
J Acquir Immune Defic Syndr; 2015 Nov; 70(3):242-9. PubMed ID: 26034880
[TBL] [Abstract][Full Text] [Related]
5. Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues.
Fletcher P; Herrera C; Armanasco N; Nuttall J; Shattock RJ
AIDS Res Hum Retroviruses; 2016 Apr; 32(4):334-8. PubMed ID: 26711323
[TBL] [Abstract][Full Text] [Related]
6. Protection Against Rectal Chimeric Simian/Human Immunodeficiency Virus Transmission in Macaques by Rectal-Specific Gel Formulations of Maraviroc and Tenofovir.
Dobard CW; Taylor A; Sharma S; Anderson PL; Bushman LR; Chuong D; Pau CP; Hanson D; Wang L; Garcia-Lerma JG; McGowan I; Rohan L; Heneine W
J Infect Dis; 2015 Dec; 212(12):1988-95. PubMed ID: 26071566
[TBL] [Abstract][Full Text] [Related]
7. HIV pre-exposure prophylaxis: mucosal tissue drug distribution of RT inhibitor Tenofovir and entry inhibitor Maraviroc in a humanized mouse model.
Veselinovic M; Yang KH; LeCureux J; Sykes C; Remling-Mulder L; Kashuba ADM; Akkina R
Virology; 2014 Sep; 464-465():253-263. PubMed ID: 25105490
[TBL] [Abstract][Full Text] [Related]
8. Biophysical characterization of small molecule antiviral-loaded nanolipogels for HIV-1 chemoprophylaxis and topical mucosal application.
Ramanathan R; Jiang Y; Read B; Golan-Paz S; Woodrow KA
Acta Biomater; 2016 May; 36():122-31. PubMed ID: 26947382
[TBL] [Abstract][Full Text] [Related]
9. In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide.
Rohan LC; Moncla BJ; Kunjara Na Ayudhya RP; Cost M; Huang Y; Gai F; Billitto N; Lynam JD; Pryke K; Graebing P; Hopkins N; Rooney JF; Friend D; Dezzutti CS
PLoS One; 2010 Feb; 5(2):e9310. PubMed ID: 20174579
[TBL] [Abstract][Full Text] [Related]
10. Broadly Neutralizing Anti-HIV Antibodies Prevent HIV Infection of Mucosal Tissue Ex Vivo.
Scott YM; Park SY; Dezzutti CS
Antimicrob Agents Chemother; 2016 Feb; 60(2):904-12. PubMed ID: 26596954
[TBL] [Abstract][Full Text] [Related]
11. Modified silicone elastomer vaginal gels for sustained release of antiretroviral HIV microbicides.
Forbes CJ; McCoy CF; Murphy DJ; Woolfson AD; Moore JP; Evans A; Shattock RJ; Malcolm RK
J Pharm Sci; 2014 May; 103(5):1422-32. PubMed ID: 24585370
[TBL] [Abstract][Full Text] [Related]
12. Increased Dapivirine tissue accumulation through vaginal film codelivery of dapivirine and Tenofovir.
Akil A; Devlin B; Cost M; Rohan LC
Mol Pharm; 2014 May; 11(5):1533-41. PubMed ID: 24693866
[TBL] [Abstract][Full Text] [Related]
13. Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maraviroc.
Forbes CJ; Lowry D; Geer L; Veazey RS; Shattock RJ; Klasse PJ; Mitchnick M; Goldman L; Doyle LA; Muldoon BC; Woolfson AD; Moore JP; Malcolm RK
J Control Release; 2011 Dec; 156(2):161-9. PubMed ID: 21864598
[TBL] [Abstract][Full Text] [Related]
14. A topical microbicide gel formulation of CCR5 antagonist maraviroc prevents HIV-1 vaginal transmission in humanized RAG-hu mice.
Neff CP; Kurisu T; Ndolo T; Fox K; Akkina R
PLoS One; 2011; 6(6):e20209. PubMed ID: 21673796
[TBL] [Abstract][Full Text] [Related]
15. Maraviroc: a new CCR5 antagonist.
Sayana S; Khanlou H
Expert Rev Anti Infect Ther; 2009 Feb; 7(1):9-19. PubMed ID: 19622053
[TBL] [Abstract][Full Text] [Related]
16. HIV-2 susceptibility to entry inhibitors.
Borrego P; Taveira N
AIDS Rev; 2013; 15(1):49-61. PubMed ID: 23449229
[TBL] [Abstract][Full Text] [Related]
17. Brief Report: Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure Prophylaxis.
Fox J; Tiraboschi JM; Herrera C; Else L; Egan D; Dickinson L; Jackson A; Olejniczak N; Back D; Khoo S; Shattock R; Boffito M
J Acquir Immune Defic Syndr; 2016 Nov; 73(3):252-257. PubMed ID: 27727157
[TBL] [Abstract][Full Text] [Related]
18. Single oral dose of maraviroc does not prevent ex-vivo HIV infection of rectal mucosa in HIV-1 negative human volunteers.
Coll J; Moltó J; Boix J; Gómez-Mora E; Else L; García E; Paredes R; Ouchi D; Carrillo A; Escrig R; Back D; Clotet B; Cabrera C
AIDS; 2015 Oct; 29(16):2149-54. PubMed ID: 26544579
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of once-daily maraviroc plus ritonavir-boosted darunavir in pretreated HIV-infected patients in a real-life setting.
Macías J; Recio E; Márquez M; García C; Jiménez P; Merino D; Muñoz L; Pasquau J; Ojeda G; Bancalero P; Chueca N; Pineda JA
HIV Med; 2014 Aug; 15(7):417-24. PubMed ID: 24580801
[TBL] [Abstract][Full Text] [Related]
20. A silicone elastomer vaginal ring for HIV prevention containing two microbicides with different mechanisms of action.
Fetherston SM; Boyd P; McCoy CF; McBride MC; Edwards KL; Ampofo S; Malcolm RK
Eur J Pharm Sci; 2013 Feb; 48(3):406-15. PubMed ID: 23266465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
